Bristol's North Bristol NHS Trust and University Hospitals Bristol manage HIV and Hepatitis B patients across the South West of England. Tavin TDF 300mg provides Bristol patients with proven dual antiviral efficacy — effective against both HIV and Hepatitis B — at significantly reduced cost for those requiring private or supplementary supply.
Bristol's international student population from University of Bristol and UWE Bristol — including students from sub-Saharan Africa and Southeast Asia where Hepatitis B is endemic — creates specific demand for affordable TDF access for both HIV treatment and Hepatitis B management. Tavin's WHO-GMP certification ensures full clinical equivalence to brand Viread.
Visit medshopy.com or WhatsApp +91 82650 41513.
Bristol's international student population from University of Bristol and UWE Bristol — including students from sub-Saharan Africa and Southeast Asia where Hepatitis B is endemic — creates specific demand for affordable TDF access for both HIV treatment and Hepatitis B management. Tavin's WHO-GMP certification ensures full clinical equivalence to brand Viread.
Visit medshopy.com or WhatsApp +91 82650 41513.
If I have both HIV and Hepatitis B, can Tavin treat both conditions simultaneously?Yes — this is one of the most clinically valuable aspects of Tenofovir (Tavin). It has potent activity against both HIV reverse transcriptase and Hepatitis B DNA polymerase, making it uniquely effective against both viruses simultaneously. For HIV-HBV co-infected patients, international guidelines specifically recommend including TDF in the antiretroviral regimen to address both infections at once. It's critical that TDF is never stopped abruptly in co-infected patients without careful planning — discontinuation can cause severe Hepatitis B flares (hepatitis B reactivation) as the virus rebounds, which can be life-threatening. Any treatment changes in co-infected patients should always be managed by specialists experienced in both HIV and hepatology.